This case is the only non-Hodgkin lymphoma with primary central nervous system location treated in our institution in the last 10 years and represents less than 0.5% of our non-Hodgkin lymphoma series. Due to its rare occurrence, not much is known about the clinical features and treatment outcome of primary central nervous system lymphoma in pediatric patients.
Background:
Impulsivity is a complex multi-dimensional combination of behaviors which
include: ineffective impulse control, premature decision-making and inability to delay gratification.
Objective:
The aim of this work was to explore how food odor perception and its emotional value is
affected in impulsive children.
Methods:
Here we compared two cohorts of impulsive and control children with ages between 10 and
16 years. Both groups underwent a functional magnetic resonance imaging experiment, in which foodrelated
odor-cues were presented to all of them.
Results:
Differences in regions of blood oxygen level dependent activation, as well as connectivity,
were calculated. Activations were significant for all odors in the impulsive group in the temporal lobe,
cerebellum, supplementary motor area, frontal cortex, medial cingulate cortex, insula, precuneus, precentral,
para-hippocampal and calcarine cortices.
Conclusion:
Connectivity results showed that the expected emotional reward, based on odor perceived
and processed in temporal lobes, was the main cue driving responses of impulsive children. This was
followed by self-consciousness, the sensation of interaction with the surroundings and feelings of
comfort and happiness, modulated by the precuneus together with somatosensory cortex and cingulum.
Furthermore, reduced connectivity to frontal areas as well as to other sensory integration areas
(piriform cortex), combined to show different sensory processing strategies for olfactory emotional
cues in impulsive children. Finally, we hypothesize that the cerebellum plays a pivotal role in
modulating decision-making for impulsive children.
INTRODUCTION: Epilepsy is considered a health problem. 85% of patients are satisfactorily controlled with antiepileptic drugs (AEDs) and 15% have refractory seizures. The combination of omega 3 and omega 6 fatty acids (EquazenTM) can contribute to changes in ionic currents and to stabilization of neurotransmitter's function resulting in cell membrane equilibrium. These changes lead to potential seizure control. OBJECTIVE: To compare efficacy and safety in the treatment of refractory epilepsy with a supplement combining EPA, DHA (omega 3 fatty acids) and GLA (omega 6 fatty acids). METHODS: We reviewed patients from the Neurology Department of the Children's Hospital of Mexico who have refractory epilepsy, evaluating clinical characteristics of seizures, number of seizures and AEDs. 792 mg of EPA, DHA and GLA per day (6 capsules of EquazenTM) were administrated for four weeks in order to assess the frequency of seizures as well as tolerability and probable side effects. RESULTS: The study was conducted with a total of 13 patients with follow-up four weeks after the start of supplementation. We obtained a satisfactory clinical response with ≥ 80% decrease in the daily number of seizures in more than 60% of patient. The mean of number of seizures over all patients was reduced significantly from 26.61±37.2 to 5.92 daily. In addition a significant improvement in the neurocognitive capacity was observedin all patients. CONCLUSION: The co-adjuvant supplementation with EquazenTM may result in a reduction of the number of seizures in refractory epilepsy having in addition significant impact on neurocognitive aspects. To enhance the quality of life of epileptic patient supplementation with a specific combination of EPA, DHA and GLA should be reconsidered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.